The Imaging, Methodology and Statistics (IMS) core will integrate and coordinate efficient and consistent utilization of neuroimaging and statistics resources across the 3 program projects by providing standard methods and staff support that will be readily accessible to investigators. The IMS core will serve as a technical core for data acquisition, processing, and evaluation and for the development of novel analyses and software. In this manner, the IMS core will be an integral component of each project and support research that begins to address issues of the general utility, sensitivity, and specificity of PIB in the PET imaging detection of fibrillar amyloid in the brain of controls and in patients with mild cognitive impairment and Alzheimer's disease (AD) and also in Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB). The central aims of the IMS cores are to: 1) apply quantitative neuroimaging methods to measure amyloid binding, cerebral metabolic rate, and hippocampal/brain morphometry across the AD disease spectrum;2) compare amyloid binding, metabolic rate, and brain structure cross-sectionally across the AD disease spectrum and in PDD and DLB;3) determine temporal and spatial characteristics of the neuroimaging measures across time and relative to cognitive performance in the same subject groups. The program project research described in this application represents the first fully quantitative clinical evaluation of this kind performed on any amyloid imaging tracer. The core will perform a careful evaluation of the utility of PIB PET across the AD disease spectrum and in PDD and DLB by performing analyses that examine group identification (e.g., statistical classification), by applying statistical modeling to explore relationships among neuroimaging measures and measures of disease severity (e.g., MMSE) and questions involving """"""""dementia conversion"""""""". The IMS core activities will further validate PIB PET imaging for clinical application on a cross-sectional and longitudinal basis.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG025204-05
Application #
7812061
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2009-05-01
Budget End
2010-04-30
Support Year
5
Fiscal Year
2009
Total Cost
$247,520
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Hu, Ziheng; Wang, Lirong; Ma, Shifan et al. (2018) Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimers Dement (N Y) 4:542-555
Zhao, Yujing; Tudorascu, Dana L; Lopez, Oscar L et al. (2018) Amyloid ? Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia. JAMA Neurol 75:88-96
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Wilckens, Kristine A; Tudorascu, Dana L; Snitz, Beth E et al. (2018) Sleep moderates the relationship between amyloid beta and memory recall. Neurobiol Aging 71:142-148
Minhas, Davneet S; Price, Julie C; Laymon, Charles M et al. (2018) Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of A? load. Neuroimage Clin 19:182-189
Yan, Qi; Nho, Kwangsik; Del-Aguila, Jorge L et al. (2018) Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Mol Psychiatry :
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Cohen, Ann D; McDade, Eric; Christian, Brad et al. (2018) Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition. Alzheimers Dement 14:743-750
Marquié, Marta; Normandin, Marc D; Meltzer, Avery C et al. (2017) Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol 81:117-128
Mi, Zhiping; Abrahamson, Eric E; Ryu, Angela Y et al. (2017) Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease. Neurobiol Aging 55:159-166

Showing the most recent 10 out of 106 publications